Expand GLUE Menu
GLUE MENU

GLUE Stock Posts


GLUE stock increases 18.1% after hours.

After Hours Gainer

GLUE Monte Rosa Therapeutics11.93+0.19+1.6%

After Hours:14.09+2.16 (+18.1%)

Monte Rosa Therapeutics to Present Results of MRT-8102 GFORCE-1 Phase 1 Study in Subjects with Elevated Cardiovascular Disease Risk

Globe NewswireWed, 30-Sep 4:01 PM
Unusual Option Volume

GLUE Monte Rosa Therapeutics12.47-0.18 (-1.4%)

Monte Rosa Therapeutics trades 2,313 contracts. The highest volume is in the 16-Oct-26 15 calls, which is 20.3% above the current price.
View Details...
Unusual Option Volume

GLUE Monte Rosa Therapeutics14.14+0.30 (+2.2%)

Monte Rosa Therapeutics trades 2,282 contracts. The highest volume is in the 16-Oct-26 25 calls, which is 76.8% above the current price. News: Monte Rosa Therapeutics Announces Milestone Achievement Associated with Initiation of Phase 2 Clinical Study for VAV1-directed Molecular Glue Degrader MRT-6160 (DDY391)
View Details...
Unusual Option Volume

GLUE Monte Rosa Therapeutics16.08-6.60 (-29.1%)

Monte Rosa Therapeutics trades 2,156 contracts.
View Details...
Unusual Option Volume

GLUE Monte Rosa Therapeutics23.85+0.82 (+3.6%)

Monte Rosa Therapeutics trades 2,108 contracts. The highest volume is in the 16-Oct-26 25 calls, which is 4.8% above the current price.
View Details...
Unusual Option Volume

GLUE Monte Rosa Therapeutics23.32+1.03 (+4.6%)

Monte Rosa Therapeutics trades 3,015 contracts. The highest volume is in the 16-Oct-26 25 calls, which is 7.2% above the current price.
View Details...
Load Earlier Posts
Market Data Delayed 15 Minutes